The Hayflick limit, or Hayflick phenomenon, is the number of times a normal somatic, differentiated human cell population will divide before cell division stops. However, this limit does not apply to stem cells.
The concept of the Hayflick limit was advanced by American anatomist Leonard Hayflick in 1961, at the Wistar Institute in Philadelphia, Pennsylvania. Hayflick demonstrated that a normal human fetal cell population will divide between 40 and 60 times in cell culture before entering a senescence phase. This finding refuted the contention by Alexis Carrel that normal cells are immortal.
Each time a cell undergoes mitosis, the telomeres on the ends of each chromosome shorten slightly. Cell division will cease once telomeres shorten to a critical length. Hayflick interpreted his discovery to be aging at the cellular level. The aging of cell populations appears to correlate with the overall physical aging of an organism.
Macfarlane Burnet coined the name "Hayflick limit" in his book Intrinsic Mutagenesis: A Genetic Approach to Ageing, published in 1974.
The belief in cell immortalityEdit
Prior to Leonard Hayflick's discovery, it was believed that vertebrate cells had an unlimited potential to replicate. Alexis Carrel, a Nobel prize-winning surgeon, had stated "that all cells explanted in tissue culture are immortal, and that the lack of continuous cell replication was due to ignorance on how best to cultivate the cells". He claimed to have cultivated fibroblasts from the hearts of chickens (which typically live 5 to 10 years) and to have kept the culture growing for 34 years.
However, other scientists have been unable to replicate Carrel's results, and they are suspected to be due to an error in experimental procedure. To provide required nutrients, embryonic stem cells of chickens may have been re-added to the culture daily. This would have easily allowed the cultivation of new, fresh cells in the culture, so there was not an infinite reproduction of the original cells. It has been speculated that Carrel knew about this error, but he never admitted it.
Also, it has been theorized[by whom?] that the cells Carrel used were young enough to contain pluripotent stem cells, which, if supplied with a supporting telomerase-activation nutrient, would have been capable of staving off replicative senescence, or even possibly reversing it. Cultures not containing telomerase-active pluripotent stem cells would have been populated with telomerase-inactive cells, which would have been subject to the 50 ± 10 mitosis event limit until cellular senescence occurs as described in Hayflick's findings.
Experiment and discoveryEdit
Hayflick first became suspicious of Carrel's claims while working in a lab at the Wistar Institute. Hayflick noticed that one of his cultures of embryonic human fibroblasts had developed an unusual appearance and that cell division had slowed. Initially, he brushed this aside as an anomaly caused by contamination or technical error. However, he later observed other cell cultures exhibiting similar manifestations. Hayflick checked his research notebook and was surprised to find that the atypical cell cultures had all been cultured to approximately their 40th doubling while younger cultures never exhibited the same problems. Furthermore, conditions were similar between the younger and older cultures he observed — same culture medium, culture containers, and technician. This led him to doubt that the manifestations were due to contamination or technical error.
Hayflick next set out to prove that the cessation of normal cell replicative capacity that he observed was not the result of viral contamination, poor culture conditions or some unknown artifact. Hayflick teamed with Paul Moorhead for the definitive experiment to eliminate these as causative factors. As a skilled cytogeneticist, Moorhead was able to distinguish between male and female cells in culture. The experiment proceeded as follows: Hayflick mixed equal numbers of normal human male fibroblasts that had divided many times (cells at the 40th population doubling) with female fibroblasts that had divided fewer times (cells at the 15th population doubling). Unmixed cell populations were kept as controls. After 20 doublings of the mixed culture, only female cells remained. Cell division ceased in the unmixed control cultures at the anticipated times; when the male control culture stopped dividing, only female cells remained in the mixed culture. This suggested that technical errors or contaminating viruses were unlikely explanations as to why cell division ceased in the older cells, and proved that unless the virus or artifact could distinguish between male and female cells (which it could not) then the cessation of normal cell replication was governed by an internal counting mechanism.
These results disproved Carrel's immortality claims and established the Hayflick limit as a credible biological theory. Unlike Carrel's experiment, Hayflick's have been successfully repeated by other scientists.
However, L. Franks and others (Loo et al. 1987; Nooden and Tompson 1995; Frolkis 1988a), have shown that the number of cell divisions can be considerably greater than that stipulated by the Hayflick limit, having practically no limit at all.
Hayflick describes three phases in the life of normal cultured cells. At the start of his experiment he named the primary culture "phase one". Phase two is defined as the period when cells are proliferating; Hayflick called this the time of "luxuriant growth". After months of doubling the cells eventually reach phase three, a phenomenon he named "senescence", where cell replication rate slows before halting altogether.
The Hayflick limit has been found to correlate with the length of the telomeric region at the end of chromosomes. During the process of DNA replication of a chromosome, small segments of DNA within each telomere are unable to be copied and are lost. This occurs due to the uneven nature of DNA replication, where leading and lagging strands are not replicated symmetrically. The telomeric region of DNA does not code for any protein; it is simply a repeated code on the end region of linear eukaryotic chromosomes. After many divisions, the telomeres reach a critical length and the cell becomes senescent. It is at this point that a cell has reached its Hayflick limit.
Hayflick was the first to report that only cancer cells are immortal. This could not have been demonstrated until he had demonstrated that normal cells are mortal. Cellular senescence does not occur in most cancer cells due to expression of an enzyme called telomerase. This enzyme extends telomeres, preventing the telomeres of cancer cells from shortening and giving them infinite replicative potential. A proposed treatment for cancer is the usage of telomerase inhibitors that would prevent the restoration of the telomere, allowing the cell to die like other body cells.
Hayflick suggested that his results in which normal cells have a limited replicative capacity may have significance for understanding human aging at the cellular level.
It has been reported that the limited replicative capability of human fibroblasts observed in cell culture is far greater than the number of replication events experienced by non-stem cells in vivo during a normal postnatal lifespan. In addition, it has been suggested that no inverse correlation exists between the replicative capacity of normal human cell strains and the age of the human donor from which the cells were derived, as previously argued. It is now clear that at least some of these variable results are attributable to the mosaicism of cell replication numbers at different body sites where cells were taken.
Comparisons of different species indicate that cellular replicative capacity may correlate primarily with species body mass, but more likely to species lifespan. Thus, the limited capacity of cells to replicate in culture may be directly relevant to organismal aging.
- ^ Rodriguez-Brenes, Ignacio A.; Wodarz, Dominik; Komarova, Natalia L. (December 9, 2015). "Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy". Scientific Reports. 5: 17660. Bibcode:2015NatSR...517660R. doi:10.1038/srep17660. PMC 4673423. PMID 26647820.
- ^ Petersen, Thomas; Niklason, Laura (September 2007). "Cellular Lifespan and Regenerative Medicine". Biomaterials. 28 (26): 3751–3756. doi:10.1016/j.biomaterials.2007.05.012. PMC 2706083. PMID 17574669.
- ^ a b c d e Hayflick L, Moorhead PS (1961). "The serial cultivation of human diploid cell strains". Exp Cell Res. 25 (3): 585–621. doi:10.1016/0014-4827(61)90192-6. PMID 13905658.
- ^ a b c d Hayflick L. (1965). "The limited in vitro lifetime of human diploid cell strains". Exp. Cell Res. 37 (3): 614–636. doi:10.1016/0014-4827(65)90211-9. PMID 14315085.
- ^ a b c d Shay, JW; Wright, WE (October 2000). "Hayflick, his limit, and cellular ageing". Nature Reviews Molecular Cell Biology. 1 (1): 72–6. doi:10.1038/35036093. PMID 11413492. S2CID 6821048.
- ^ Carrel A, Ebeling AH (1921). "Age and multiplication of fibroblasts". J. Exp. Med. 34 (6): 599–606. doi:10.1084/jem.34.6.599. PMC 2128071. PMID 19868581.
- ^ Witkowski JA (1985). "The myth of cell immortality". Trends Biochem. Sci. 10 (7): 258–260. doi:10.1016/0968-0004(85)90076-3.
- ^ Witkowski JA (1980). "Dr. Carrel's immortal cells". Med. Hist. 24 (2): 129–142. doi:10.1017/S0025727300040126. PMC 1082700. PMID 6990125.
- ^ a b Hayflick, L (19 May 2016). "Unlike Aging, Longevity is Sexually Determined". In Bengtson, VL; Settersten, RA (eds.). Handbook of Theories of Aging (Third ed.). Springer Publishing Company. pp. 31–52. ISBN 9780826129420.
- ^ Watson JD (1972). "Origin of concatemeric T7 DNA". Nature New Biology. 239 (94): 197–201. doi:10.1038/newbio239197a0. PMID 4507727.
- ^ Rousseau, Philippe; Autexier, Chantal (October 2015). "Telomere biology: Rationale for diagnostics and therapeutics in cancer". RNA Biology. 12 (10): 1078–1082. doi:10.1080/15476286.2015.1081329. PMC 4829327. PMID 26291128.
- ^ Olovnikov AM (1996). "Telomeres, telomerase and aging: Origin of the theory". Exp. Gerontol. 31 (4): 443–448. doi:10.1016/0531-5565(96)00005-8. PMID 9415101. S2CID 26381790.
- ^ Olovnikov, A. M. (1971). "Принцип маргинотомии в матричном синтезе полинуклеотидов" [Principles of marginotomy in template synthesis of polynucleotides]. Doklady Akademii Nauk SSSR. 201 (6): 1496–1499. PMID 5158754.
- ^ Feng F; et al. (1995). "The RNA component of human telomerase". Science. 269 (5228): 1236–1241. Bibcode:1995Sci...269.1236F. doi:10.1126/science.7544491. PMID 7544491. S2CID 9440710.
- ^ Wright WE, Shay JW (2000). "Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology". Nature Medicine. 6 (8): 849–851. doi:10.1038/78592. PMID 10932210. S2CID 20339035.
- ^ a b Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC (1998). "Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation". Proc. Natl. Acad. Sci. U.S.A. 95 (18): 10614–9. Bibcode:1998PNAS...9510614C. doi:10.1073/pnas.95.18.10614. PMC 27943. PMID 9724752.
- Watts, Geoff (2011). "Leonard Hayflick and the limits of ageing". The Lancet. 377 (9783): 2075. doi:10.1016/S0140-6736(11)60908-2. PMID 21684371. S2CID 205963134.
- Harley, Calvin B.; Futcher, A. Bruce; Greider, Carol W. (1990). "Telomeres shorten during ageing of human fibroblasts". Nature. 345 (6274): 458–60. Bibcode:1990Natur.345..458H. doi:10.1038/345458a0. PMID 2342578. S2CID 1145492.
- Gavrilov LA, Gavrilova NS (1991). The Biology of Life Span: A Quantitative Approach. New York: Harwood Academic Publisher. ISBN 3-7186-4983-7.
- Gavrilov LA, Gavrilova NS (1993). "How many cell divisions in 'old' cells?". Int. J. Geriatr. Psychiatry. 8 (6): 528.
- Wang, Richard C.; Smogorzewska, Agata; De Lange, Titia (2004). "Homologous Recombination Generates T-Loop-Sized Deletions at Human Telomeres". Cell. 119 (3): 355–68. doi:10.1016/j.cell.2004.10.011. PMID 15507207. S2CID 10686288.
- Watson, J. M.; Shippen, D. E. (2006). "Telomere Rapid Deletion Regulates Telomere Length in Arabidopsis thaliana". Molecular and Cellular Biology. 27 (5): 1706–15. doi:10.1128/MCB.02059-06. PMC 1820464. PMID 17189431.